LUIS JAVIER MARTÍNEZ GONZÁLEZ-rekin lankidetzan egindako argitalpenak (7)

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

2018

  1. Methodology for y Chromosome Capture: A complete genome sequence of y chromosome using flow cytometry, laser microdissection and magnetic streptavidin-beads

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk

    Urologic Oncology: Seminars and Original Investigations, Vol. 34, Núm. 10, pp. 431.e1-431.e8

  2. Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty

    Pharmacogenomics, Vol. 17, Núm. 12, pp. 1327-1338

2015

  1. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: A meta-analysis

    Pharmacogenetics and Genomics, Vol. 25, Núm. 8, pp. 388-393

  2. Prognostic role of genetic biomarkers in clinical progression of prostate cancer

    Experimental and Molecular Medicine, Vol. 47, Núm. 8

2009

  1. High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 150, Núm. 3, pp. 395-402